U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07303101) titled 'One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to go' on Dec. 11.
Brief Summary: Accounting for only 0.7% to 3% of joint prosthesis infections, yeast infections are considered particularly difficult to treat. They are primarily caused by Candida yeasts, representing over 90% of cases.
Surgical treatment is the cornerstone of managing periprosthetic infections. In cases of chronic bacterial infections, complete implant replacement is necessary and can be performed either in one or two stages.
However, for chronic Candida spp. infections, two-stage prosthesis replacement remains the preferred option. Only thre...